cyclopentane has been researched along with Carcinoma, Pancreatic Ductal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SY; Chen, YY; Hong, CJ; Hsu, YH; Wang, SY; Yen, GC | 1 |
| Jia, L; Li, H; Li, L; Liu, X; Sun, Y; Wu, J; Zhao, L; Zhou, W | 1 |
2 other study(ies) available for cyclopentane and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cyclopentanes; HMGB1 Protein; Humans; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor for Advanced Glycation End Products; Signal Transduction | 2022 |
Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine.
Topics: Adenocarcinoma; Adult; Aged; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Deoxycytidine; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; NEDD8 Protein; Pyrimidines; Ubiquitin-Activating Enzymes; Ubiquitins; Xenograft Model Antitumor Assays | 2017 |